206 related articles for article (PubMed ID: 10334551)
1. Role of FHIT in human cancer.
Croce CM; Sozzi G; Huebner K
J Clin Oncol; 1999 May; 17(5):1618-24. PubMed ID: 10334551
[TBL] [Abstract][Full Text] [Related]
2. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
5. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
6. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
7. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
[TBL] [Abstract][Full Text] [Related]
8. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
9. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
Sozzi G; Tornielli S; Tagliabue E; Sard L; Pezzella F; Pastorino U; Minoletti F; Pilotti S; Ratcliffe C; Veronese ML; Goldstraw P; Huebner K; Croce CM; Pierotti MA
Cancer Res; 1997 Dec; 57(23):5207-12. PubMed ID: 9393735
[TBL] [Abstract][Full Text] [Related]
10. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
11. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
Geradts J; Fong KM; Zimmerman PV; Minna JD
Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
[TBL] [Abstract][Full Text] [Related]
12. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T
Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157
[TBL] [Abstract][Full Text] [Related]
14. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
[TBL] [Abstract][Full Text] [Related]
15. The role of the FHIT/FRA3B locus in cancer.
Huebner K; Garrison PN; Barnes LD; Croce CM
Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
[TBL] [Abstract][Full Text] [Related]
16. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
[TBL] [Abstract][Full Text] [Related]
17. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
18. Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
Uematsu K; Yoshimura A; Gemma A; Mochimaru H; Hosoya Y; Kunugi S; Matsuda K; Seike M; Kurimoto F; Takenaka K; Koizumi K; Fukuda Y; Tanaka S; Chin K; Jablons DM; Kudoh S
Cancer Res; 2001 Dec; 61(23):8527-33. PubMed ID: 11731438
[TBL] [Abstract][Full Text] [Related]
19. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
Li L; An Q; Feng X
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
[TBL] [Abstract][Full Text] [Related]
20. Loss of FHIT expression in gastric carcinoma.
Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
